These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management. Gordin A; Golz A; Daitzchman M; Keidar Z; Bar-Shalom R; Kuten A; Israel O Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):370-6. PubMed ID: 17324532 [TBL] [Abstract][Full Text] [Related]
38. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer. Khiewvan B; Torigian DA; Emamzadehfard S; Paydary K; Salavati A; Houshmand S; Shamchi SP; Werner TJ; Aydin A; Roy SG; Alavi A; Kumar R Hell J Nucl Med; 2016; 19(3):254-268. PubMed ID: 27824966 [TBL] [Abstract][Full Text] [Related]
39. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma. Lee JW; Nam SB; Kim SJ Oncology; 2019; 97(5):286-293. PubMed ID: 31437839 [TBL] [Abstract][Full Text] [Related]
40. FDG-PET/CT for oral focus assessment in head and neck cancer patients. Schwaninger DR; Hüllner M; Bichsel D; Giacomelli-Hiestand B; Stutzmann NS; Balermpas P; Valdec S; Stadlinger B Clin Oral Investig; 2022 Jun; 26(6):4407-4418. PubMed ID: 35254526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]